Published in Cancer on September 15, 1997
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Therapy for alcoholic liver disease. World J Gastroenterol (2014) 1.17
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg (1999) 1.02
De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99
Clinical management of inflammatory bowel disease in the organ recipient. World J Gastroenterol (2014) 0.86
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78
De novo cancers following liver transplantation: a single center experience in China. PLoS One (2014) 0.77
Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77
Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22. JCI Insight (2016) 0.76
Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol (2015) 0.76
Nephrectomy for a renal metastasis of undiagnosed hepatocellular carcinoma arising from an orthotopic liver transplant undertaken for cryptogenic cirrhosis. Korean J Urol (2013) 0.75
The incidence and risk factors of de novo skin cancer in the liver transplant recipients. Int J Organ Transplant Med (2012) 0.75
Study of factors affecting the incidence of skin cancer in patients after liver transplant. An Bras Dermatol (2017) 0.75
De novo lung cancer diagnosed 32 months after liver transplantation: report of a case. Surg Today (2011) 0.75
Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation (2017) 0.75
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26
Retracted Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br J Surg (2005) 3.06
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant (2011) 2.54
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood (2001) 2.50
Sexual segregation in ungulates: a comparative test of three hypotheses. Biol Rev Camb Philos Soc (2002) 2.34
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics (2001) 2.21
The impact of carbon dioxide pneumoperitoneum on liver regeneration after liver resection in a rat model. Surg Endosc (2009) 2.16
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology (1998) 1.98
Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy. J Hepatol (2010) 1.95
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology (1996) 1.86
Management and outcome of patients with combined bile duct and hepatic arterial injuries after laparoscopic cholecystectomy. Surgery (2004) 1.82
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg (2008) 1.74
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67
C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant (2006) 1.62
Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia. Acta Radiol (2006) 1.59
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. Radiology (1997) 1.52
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50
Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology (1998) 1.49
Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology (2000) 1.48
Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int (1996) 1.47
The laparoscopic Janeway gastrostomy. An alternative technique when percutaneous endoscopic gastrostomy is impractical. Endoscopy (2001) 1.46
Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol (2005) 1.46
Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy. Br J Surg (2011) 1.46
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Transplantation (1999) 1.43
Venous complications after orthotopic liver transplantation. Clin Transplant (2000) 1.43
Selective susceptibility of CD34-expressing cells to acquire flow cytometric features of apoptosis/necrosis on exposure to an ammonium chloride-based red blood cell lysing reagent. J Hematother (1998) 1.42
Interference of blood leucocytes in the measurements of immature red cells (reticulocytes) by two different (semi-) automated flow-cytometry technologies. Clin Lab Haematol (1996) 1.42
Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg (2001) 1.40
Diagnosis of enteroceles by dynamic anorectal endosonography. Dis Colon Rectum (2000) 1.40
[Simulation of a colon carcinoma: diuretic-induced ulcerative-stricturing ischemic colitis]. Dtsch Med Wochenschr (2004) 1.39
Donor criteria in hepatic transplantation. Langenbecks Arch Chir (1994) 1.38
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
[Mesenteric artery occlusion as a rare complication of thromboangiitis obliterans]. Chirurg (2002) 1.38
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells. Xenotransplantation (2003) 1.35
Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med (1999) 1.32
Incidence, management, and outcome of stent loss during intracoronary stenting. Am J Cardiol (2001) 1.31
Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30
Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci (2000) 1.29
Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant (2013) 1.29
Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol (2011) 1.26
Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J Biol Chem (2000) 1.26
Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant (2007) 1.26
Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation (1993) 1.24
Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut (1996) 1.22
Regulatory peptide receptors in human hepatocellular carcinomas. Gut (1999) 1.22
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules. Exp Clin Endocrinol Diabetes (2009) 1.21
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood (1994) 1.20
Transabdominal ligation of the thoracic duct as treatment of choice for postoperative chylothorax after esophagectomy. Dis Esophagus (2007) 1.19
ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A (1998) 1.17
Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest (1992) 1.17
Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg (1994) 1.15
Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.14
Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology (1992) 1.13
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. Transplant Proc (1999) 1.09
Occurrence of Campylobacter spp. in young gulls, duration of Campylobacter infection and reinfection by contact. Zentralbl Veterinarmed B (1992) 1.09
Liver resection for metastases from renal cell carcinoma. World J Surg (2007) 1.09
[Therapy of primary hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.08
[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres]. Z Gastroenterol (2011) 1.07
[Diagnostic imaging of hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.06
Human acid ceramidase: processing, glycosylation, and lysosomal targeting. J Biol Chem (2001) 1.06
The influence of OKT8F treatment on allograft survival in rhesus monkeys. Transplantation (1986) 1.06
Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis. Br J Cancer (2003) 1.05
Selective labelling of lymphoid tissues by extracorporeal perfusion. J Immunol Methods (1980) 1.05
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br J Pharmacol (2009) 1.05
Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity (1998) 1.04
Surgical complications and long-term outcome of different biliary reconstructions in liver transplantation for primary sclerosing cholangitis-choledochoduodenostomy versus choledochojejunostomy. Am J Transplant (2006) 1.04